Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10592114rdf:typepubmed:Citationlld:pubmed
pubmed-article:10592114lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:10592114lifeskim:mentionsumls-concept:C0927232lld:lifeskim
pubmed-article:10592114lifeskim:mentionsumls-concept:C0206734lld:lifeskim
pubmed-article:10592114lifeskim:mentionsumls-concept:C0019562lld:lifeskim
pubmed-article:10592114lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:10592114pubmed:issue11lld:pubmed
pubmed-article:10592114pubmed:dateCreated2000-1-31lld:pubmed
pubmed-article:10592114pubmed:abstractTextThe aim was to assess the frequency of von Hippel-Lindau disease (VHL) and the long-term prognosis of VHL and non-VHL patients among 110 consecutive patients with haemangioblastoma (HB) of the CNS treated between 1953 and 1993 at one neurosurgical unit. To reveal VHL manifestations we performed a detailed clinical and radiological examination (neuraxis and abdomen) (61/110), VHL-gene mutation analysis (40/110), and collection of all available clinical, imaging, operative and autopsy data from the hospitals involved. All patients were followed-up with a median of 14 years (excluding 14 operative deaths), and no patient was lost to follow-up. Altogether 49 patients died during the follow-up. In the 14 VHL patients (13%), HB(s) of the CNS were detected at a median age of 33 years, retinal HB(s) at 39 years, and renal cell carcinoma (RCC) at 43 years. The frequency of VHL in patients operated on for HB(s) was 29% before the age of 25 years, 19% between 25 and 45 years, and only 2% after 45 years. HB patients not meeting the VHL criteria had internal organ cysts in 14%. One non-VHL patient (4%) had two adjacent HBs in the same cyst wall. The growth rates of non-VHL and VHL-related HBs were similar as indicated by the median time to recurrence and the proliferation indices (MIB-1). Recurrence of the HB in patients whose primary operation was considered radical developed in four of the 10 VHL patients at a median of 19 years, and in nine of the 74 non-VHL patients at a median of 11 years. The median length of life of all VHL and non-VHL patients was 46 and 63 years, respectively. In VHL, RCC and HBs were equal causes of death.lld:pubmed
pubmed-article:10592114pubmed:languageenglld:pubmed
pubmed-article:10592114pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10592114pubmed:citationSubsetIMlld:pubmed
pubmed-article:10592114pubmed:statusMEDLINElld:pubmed
pubmed-article:10592114pubmed:issn0001-6268lld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:JääskeläinenJ...lld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:KeroPPlld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:PukkalaEElld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:NiemeläMMlld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:SummanenPPlld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:BöhlingTTlld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:HaapasaloHHlld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:SankilaRRlld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:KääriäinenHHlld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:SainioMMlld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:PoussaKKlld:pubmed
pubmed-article:10592114pubmed:authorpubmed-author:LemetaSSlld:pubmed
pubmed-article:10592114pubmed:issnTypePrintlld:pubmed
pubmed-article:10592114pubmed:volume141lld:pubmed
pubmed-article:10592114pubmed:ownerNLMlld:pubmed
pubmed-article:10592114pubmed:authorsCompleteYlld:pubmed
pubmed-article:10592114pubmed:pagination1147-56lld:pubmed
pubmed-article:10592114pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:meshHeadingpubmed-meshheading:10592114...lld:pubmed
pubmed-article:10592114pubmed:year1999lld:pubmed
pubmed-article:10592114pubmed:articleTitleLong-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease.lld:pubmed
pubmed-article:10592114pubmed:affiliationDepartment of Neurosurgery, Helsinki University Hospital, Helsinki, Finland.lld:pubmed
pubmed-article:10592114pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10592114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10592114lld:pubmed